EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduction in Liver Cancer Risk by Quercetin via Modulation of Urate Levels: Insights from Drug-Target Mendelian Randomization

Zhengwen Li, Yue Wang, Kaichuan Yang, Chujie Li iD, Ming Zhang

Genes · 2025

DOI: 10.3390/genes16040449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Zhengwen Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu University, 2025 Chengluo Avenue, Chengdu 610106, China. Hauptthemen laut MEDLINE: Quercetin, ATP Binding Cassette Transporter, Subfamily G, Member 2, Liver Neoplasms, Uric Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Talent Introduction Project of Chengdu University (X2107, Y2021066)., National Natural Science Foundation of China, Talent Introduction Project of Chengdu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quercetin, a dietary flavonoid and a widely used supplement, has hepatoprotective properties. Given its urate-lowering effects and epidemiological evidence linking elevated serum urate levels to liver cancer risk, we tested whether quercetin reduces liver cancer risk via modulation of urate levels by bioinformatics methods.

Methods

We employed drug-target Mendelian randomization using genome-wide association study summary statistics from public databases (e.g., MRC-IEU) to assess genetic associations, and integrated these findings with GEO datasets (such as GSE138709 and GSE179443) and immune infiltration analyses using tools like xCell, TIMER.

Results

Our analyses identified ABCG2-mediated urate elevation as a causal risk factor for hepatocellular carcinoma (OR = 1.001, p < 0.01), cholangiocarcinoma (OR = 3.424, p < 0.01), and liver fibrosis (OR = 2.528, p < 0.01). Single-cell transcriptomics revealed elevated ABCG2 expression in cholangiocarcinoma endothelial cells, while immune infiltration analysis showed significant associations between ABCG2 expression and both endothelial cell and macrophage infiltration. Survival analysis further indicated that ABCG2 was not associated with poor prognosis in cholangiocarcinoma or hepatocellular carcinoma.

Conclusions

Considering quercetin’s multifaceted interactions with BCRP/ABCG2, our findings support its potential use as a preventive dietary supplement for hepatic diseases rather than as an adjunctive therapy for established liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinATP Binding Cassette Transporter, Subfamily G, Member 2Liver NeoplasmsUric AcidCarcinoma, HepatocellularHumansMendelian Randomization AnalysisGenome-Wide Association StudyNeoplasm ProteinsCholangiocarcinomaRisk FactorsPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

drug-target Mendelian randomizationliver cancerquercetinurate

Substanzen

QuercetinATP Binding Cassette Transporter, Subfamily G, Member 2ABCG2 protein, humanUric AcidNeoplasm Proteins

Autor:innen und Institutionen

  • School of Pharmacy, Chengdu University, 2025 Chengluo Avenue, Chengdu 610106, China.
  • Cell Biology-Inspired Tissue Engineering, Institute for Technology-Inspired, Regenerative Medicine, Maastricht University, 6200 MD Maastricht, The Netherlands.
  • Precision Medicine, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands.
  • College of Food Science and Engineering, Hainan University, 58 Renmin Road, Haikou 570228, China.

ORCID-Profile: Chujie Li

Förderung

  • Talent Introduction Project of Chengdu University (X2107, Y2021066).
  • National Natural Science Foundation of China
  • Talent Introduction Project of Chengdu University

Zitieren

APA

Li, Z., Wang, Y., Yang, K., Li, C., & Zhang, M. (2025). Reduction in Liver Cancer Risk by Quercetin via Modulation of Urate Levels: Insights from Drug-Target Mendelian Randomization. Genes. https://doi.org/10.3390/genes16040449

Vancouver

Li Z, Wang Y, Yang K, Li C, Zhang M. Reduction in Liver Cancer Risk by Quercetin via Modulation of Urate Levels: Insights from Drug-Target Mendelian Randomization. Genes. 2025. doi:10.3390/genes16040449

BibTeX
@article{Li2025,
  author = {Li, Zhengwen and Wang, Yue and Yang, Kaichuan and Li, Chujie and Zhang, Ming},
  title = {Reduction in Liver Cancer Risk by Quercetin via Modulation of Urate Levels: Insights from Drug-Target Mendelian Randomization},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16040449}
}
Kostenlos starten →